Bayer Baycol documents subpoenaed
Executive Summary
FDA and Department of Defense initiate joint investigation into Bayer's withdrawn statin Baycol, company says in 1April 8 filing with Securities & Exchange Commission. Bayer received a subpoena for documents from the Defense Criminal Investigative Service in January. Bayer supplied Baycol (cerivastatin) under contract to the DoD prior to the withdrawal of the cholesterol-lowering agent in August 2001. Merck's Zocor was the only other statin on formulary at the time of the withdrawal...